Opioid Risk Tool (ORT) for Narcotic Abuse

ORT Calculator
Sex
Family History: Alcohol Abuse
Family History: Illegal Drug Abuse
Family History: Prescription Drug Abuse
Personal History: Alcohol Abuse
Personal History: Illegal Drug Abuse
Personal History: Prescription Drug Abuse
Age 16-45 Years
History of Preadolescent Sexual Abuse
ADD, ADHD, or OCD
Bipolar Disorder
Schizophrenia
Depression
Result: 0
Estimates risk of opioid-related aberrant behaviors.

Why Use

Substance use, particularly of prescribed drugs, has been an increasing problem in the United States. It is reasonable to consider risk of future abuse/diversion/misuse, especially if considering prescribing narcotics to high risk patients.

When to Use

The ORT may help identify patients at high risk for misuse, and who who might benefit more from other modalities of pain control besides narcotics (primarily applicable to patients with chronic pain).

Formula

Addition of the selected points. Complete scoring information can be found in the derivation study .

Advice

Pain medications should not be withheld for painful conditions simply because a patient is deemed “high risk” by the ORT, but these patients should be considered for other modalities of pain control if appropriate. These high risk patients may be appropriate candidates for referral to pain management. Providers should exercise caution when starting any patient on chronic opiates.

More Information

Score interpretation: Low risk: 0–3. Moderate risk: 4–7. High risk: ≥ 8. Other Notes: 185 patients were followed in chronic pain clinic. Tracked to determine who developed "aberrant behaviors". Developed a score based on this to calculate this risk. Of note, still 5% of "low-risk" patients still had aberrant behaviors.. Aberrant behaviors included a long list of behaviors indicating possible abuse, including but not limited to: Used additional opioids than those prescribed. Requested refills instead of clinic visit. Canceled clinic visit. Solicited opioids from other providers. Unauthorized ER visits.

Oh hi there 👋
It’s nice to meet you.

New scoring tools, dose references, and guideline summaries straight to your inbox.

We don’t spam! Read our privacy policy for more info.

Similar Posts

Leave a Reply

Your email address will not be published. Required fields are marked *